ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

8 links0 made here, not in the record15 judgments2 judges (the rules as one: Rule based)4 record changes seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Sep 28Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT04310007Testing the Addition of thePill Chemotherapy,Cabozantinib, to theStandard Immune TherapyNivolumab Compared toStandard Chemotherapy forNon-small Cell Lung CancerNational Cancer Institute (NCIPhase 2 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Sep 29 · ClinicalTrials.gov record · Version of 2026-09-29Oct 22 · ClinicalTrials.gov record · Version of 2026-10-22Oct 26 · ClinicalTrials.gov record · Version of 2026-10-26Nov 12 · ClinicalTrials.gov record · Version of 2026-11-12Version of 2026-11-12CONDITIONSLung NeoplasmsThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSCabozantinibEntry “Cabozantinib S-malate”, read b…›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedDocetaxelIntervention entry›Nov 2 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorGemcitabineEntry “Gemcitabine Hydrochloride”, re…›Nov 2 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorAlbumin-Bound PaclitaxelEntry “Nab-paclitaxel”, read by our n…›Nov 2 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorNivolumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPaclitaxelIntervention entry›Nov 2 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorRamucirumabIntervention entry›Nov 2 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparator

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Cabozantinib

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Cabozantinib S-malate”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Sep 29The record itselfClinicalTrials.gov recordVersion of 2026-09-29Record change
Oct 22The record itselfClinicalTrials.gov recordVersion of 2026-10-22Record change
Oct 26The record itselfClinicalTrials.gov recordVersion of 2026-10-26Record change
Nov 2CabozantinibClaude Opus 5.5TestedCurrent
Nov 2DocetaxelClaude Opus 5.5ComparatorCurrent
Nov 2GemcitabineClaude Opus 5.5ComparatorCurrent
Nov 2Albumin-Bound PaclitaxelClaude Opus 5.5ComparatorCurrent
Nov 2NivolumabClaude Opus 5.5TestedCurrent
Nov 2PaclitaxelClaude Opus 5.5ComparatorCurrent
Nov 2RamucirumabClaude Opus 5.5ComparatorCurrent
Nov 12The record itselfClinicalTrials.gov recordVersion of 2026-11-12Record change
Nov 18CabozantinibRule based · role ruleTestedAgrees
Nov 18DocetaxelRule based · role ruleComparatorAgrees
Nov 18GemcitabineRule based · role ruleComparatorAgrees
Nov 18Albumin-Bound PaclitaxelRule based · role ruleComparatorAgrees
Nov 18NivolumabRule based · role ruleTestedAgrees
Nov 18PaclitaxelRule based · role ruleComparatorAgrees
Nov 18RamucirumabRule based · role ruleComparatorAgrees
As of nowLung NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.